advertisement

Shedding Light on nAMD: The Latest Advances in Treating Neovascular Age-Related Macular Degeneration

Live Virtual Symposium
Approved for AMA PRA Category 1 Credit™

Live Broadcast
1.50 available credits
Information
May 23, 2022
20:00 - 22:00 EDT
Shedding Light on nAMD The Latest Advances in Treating Neovascular AgeRelated Macular Degeneration
Details
Presenters
  • Overview

    Join us for this live virtual symposium on neovascular age-related macular degeneration. Drs. Holekamp, Clark, and Kitchens will discuss strategies to incorporate cutting-edge treatments into practice and tips to identify which patients may benefit from next-generation therapies.

    This activity is supported by an educational grant from Genentech, a member of the Roche Group.

     

    Accreditation & Designation Statements

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Details
Presenters
  • Overview

    Join us for this live virtual symposium on neovascular age-related macular degeneration. Drs. Holekamp, Clark, and Kitchens will discuss strategies to incorporate cutting-edge treatments into practice and tips to identify which patients may benefit from next-generation therapies.

    This activity is supported by an educational grant from Genentech, a member of the Roche Group.

     

    Accreditation & Designation Statements

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Register

We're glad to see you're enjoying Evolve Medical Education…
but how about a more personalized experience?

Register for free